Edition:
United States

Acorda Therapeutics Inc (ACOR.OQ)

ACOR.OQ on NASDAQ Stock Exchange Global Select Market

18.23USD
15 Oct 2018
Change (% chg)

-- (--)
Prev Close
$18.23
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
213,657
52-wk High
$36.25
52-wk Low
$15.65

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -1.09 December 16 Oct 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 2 2
(3) HOLD 6 6 6 5
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.89 2.89 2.89 2.88

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 10 30.03 52.20 8.50 90.37
Quarter Ending Mar-19 5 24.79 47.00 13.50 --
Year Ending Dec-18 10 367.24 412.30 333.13 437.14
Year Ending Dec-19 10 130.81 270.38 82.00 306.06
Earnings (per share)
Quarter Ending Dec-18 6 -1.09 -0.66 -1.44 -0.31
Quarter Ending Mar-19 4 -1.10 -0.95 -1.25 --
Year Ending Dec-18 6 0.18 1.13 -1.38 0.73
Year Ending Dec-19 6 -3.40 -1.77 -4.36 -2.73

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 138.63 153.30 14.67 10.58
Quarter Ending Mar-18 129.87 106.17 23.70 18.25
Quarter Ending Dec-17 171.72 188.40 16.68 9.71
Quarter Ending Sep-17 150.63 141.07 9.57 6.35
Quarter Ending Jun-17 140.07 139.44 0.63 0.45
Earnings (per share)
Quarter Ending Jun-18 0.71 1.40 0.69 95.80
Quarter Ending Mar-18 0.47 0.14 0.33 70.42
Quarter Ending Dec-17 1.05 0.61 0.44 41.90
Quarter Ending Sep-17 0.65 0.43 0.22 34.14
Quarter Ending Jun-17 0.48 0.29 0.19 39.04

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 30.03 32.43 37.11 37.06 90.37
Quarter Ending Mar-19 24.79 30.55 50.44 50.44 --
Year Ending Dec-18 367.24 370.20 376.53 370.42 437.14
Year Ending Dec-19 130.81 145.28 158.85 166.52 306.06
Earnings (per share)
Quarter Ending Dec-18 -1.09 -1.02 -0.97 -0.89 -0.31
Quarter Ending Mar-19 -1.10 -0.97 -0.63 -0.63 --
Year Ending Dec-18 0.18 0.26 0.26 0.20 0.73
Year Ending Dec-19 -3.40 -2.99 -2.84 -2.36 -2.73

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 1 0 6
Quarter Ending Mar-19 0 1 0 4
Year Ending Dec-18 0 1 2 4
Year Ending Dec-19 0 1 1 4
Earnings
Quarter Ending Dec-18 0 1 0 3
Quarter Ending Mar-19 0 1 0 2
Year Ending Dec-18 0 1 1 2
Year Ending Dec-19 0 1 1 2